Be sure to review the full Instructions for Use for Toujeo^® that comes with your prescription before injecting
Toujeo^® is injected under your skin
Change (rotate) your injection sites within the area you chose with each dose. Do not use the same spot for subsequent injection

Injection Sites

Stomach-Inject anywhere except for a 2-inch radius around navel.
Thighs-Avoid injecting too close to bony area above knee.
Upper arms-Inject in fatty tissue on outer back area of upper arm.

How long can I use the Toujeo® pens once they are opened?

Toujeo^® SoloStar^® can be used for up to 42 days once opened.

Keep opened pens at room temperature, below 86ºF (30ºC) away from direct heat and light
Do not refrigerate an opened Toujeo^® SoloStar^® pen

Why might I have to increase my starting dose of Toujeo®?

Your doctor may change your Toujeo^® dose several times in the first few weeks. This is to be expected. There are many reasons your doctor might increase your dose, and it’s a part of a process to help manage your blood sugar levels. If your dose increases, it doesn’t mean you’re doing anything wrong. Working together, you and your doctor will find the appropriate dose for you.

Remember:
When you start on Toujeo^®, it could take at least 5 days for Toujeo^® to reach its full activity in patients with T1DM.

Keep track of your blood sugar levels and your insulin dose, following the schedule worked out with your doctor.

Download a free

Blood Sugar Log

English Spanish

How do I process the Toujeo® co-pay?

Commercially insured patients new to Toujeo^® will pay $0 for the first 3 fills of Toujeo^®, regardless of formulary status or restrictions. Patients will then pay a $10 copay for each subsequent refill.^*

*Eligibility restrictions apply.

Ensure a patient has activated the card

Patients can register and receive an active card at toujeopro.com/support
To activate the card, go to toujeopro.com/savings or call 866-390-5622

Submitting the claim

Submit transaction to McKesson Specialty Arizona, Inc. using BIN #610524.

If primary coverage exists, input card information as secondary coverage and transmit using the COB segment of the NCPDP transaction. Applicable discounts will be displayed in the transaction response. If primary claim rejects due to formulary controls (i.e. prior authorization, NDC not covered),submit as secondary using Other Coverage Code (OCC) of 3 along with the Primary Rejection Code.
For questions regarding setup, claim transmission, patient’s eligibility or other issues, call the McKesson help line at 1-855-262-5295 (8:00 AM – 8:00 PM EST, Monday-Friday).

For full offer terms please visit ToujeoTrialOffer.com

Clinical Publications

Use the links below to read the study abstracts at PubMed.gov.

EDITION 3

Insulin-naive patients with type 2 diabetes mellitus on oral glucose-lowering drugs.

EDITION 1

Patients with type 2 diabetes mellitus using basal and mealtime insulin.

Clamp Study I

Evaluated the steady-state PK/PD profile of Toujeo^®.

EDITION 2

Patients with type 2 diabetes mellitus using oral antidiabetic agents and basal insulin.

EDITION 4

Patients with type 1 diabetes mellitus.

Clamp Study II

Evaluated the day-to-day and intraday variability of Toujeo^®.

Toujeo^® has been studied versus Lantus^® (insulin glargine injection) 100 Units/mL in four pivotal clinical trials (the EDITION study program)^a involving more than 3000 patients and in two euglycemic clamp studies to assess pharmacokinetics (PK) and pharmacodynamics (PD).

^aAll studies in the EDITION clinical program were 26-week, open-label,controlled, titrate-to-target, noninferiority studies in adults with diabetes not at A1C goal (range: 7%-10% or 11%), randomized to Toujeo^® or Lantus^® once daily. All patients were titrated to an FPG goal of 80-100 mg/dL (T2DM) or 80-130 mg/dL (T1DM).

Request a Sales Rep

Get product materials and assistance from reps in your area

Request a Rep

Additional Resources to Support Patients

See more resources to help educate your patients

Learn more

Register Now for Future Webcasts

Educational webcasts cover a variety of topics

Learn more

Educational resources for you and your patients

Register for free samples of the Toujeo® Pens†

Select a resource below to view, download, or print

Prescribing Information for Toujeo®

Full Toujeo® Prescribing Information

View an in-depth video hosted by KOL, Dr. John Anderson

See what key thought leaders are saying about Toujeo®

Information on the initiation and titration of Toujeo®

Toujeo® Dosing Guide

Instructions for using the Toujeo® SoloStar® pen

Toujeo® SoloStar® Instructions for Use

Instructions for using the Max SoloStar® pen

Toujeo® Max SoloStar® Instructions for Use

This video blog discusses how decisions made by payers, managed care, and insurance companies affect patient treatment options

Where coverage counts

A detailed discussion of Toujeo®, a basal insulin that can provide glycemic control for insulin-naive patients

Starting with Toujeo®

Watch a video about the long-acting mechanism of Toujeo®

How Toujeo® Works

Shows patients step-by-step instructions for using the Toujeo® pens, delivered by a medical professional and a Toujeo® patient

Using the Toujeo® Pens

Help patients learn about the free program providing tailored support from a dedicated point of contact

COACH Brochure

Completed by a healthcare professional, this form provides dosing instructions to patients

Toujeo® Titration Worksheet

In English or Spanish

Blood Sugar Log

Tips for healthier eating

Meal Planning for People with Diabetes Brochure

Tips for keeping active to stay healthy

Physical Activity for People with Diabetes Brochure

Instructions for using the Toujeo® pens

How to Prepare for and Inject Toujeo®

Tips for patients about managing hypoglycemia

Hypoglycemia Safety

FAQs about the Toujeo® co-pay program

Pharmacist Co-pay FAQs

Key features of the Max SoloStar® pen

An Introduction to Toujeo® Max SoloStar®

FAQs about the Max SoloStar® pen

Toujeo® Max SoloStar® Pharmacy FAQs

Frequently Asked Questions

Select a question below for helpful information

How do I dose Toujeo®?

The recommended starting dose of Toujeo® is based on prior treatment

After you start Toujeo®

Where should I inject Toujeo®?

Injection Sites

How long can I use the Toujeo® pens once they are opened?

Why might I have to increase my starting dose of Toujeo®?

Blood Sugar Log

How do I process the Toujeo® co-pay?

Clinical Publications

Use the links below to read the study abstracts at PubMed.gov.

EDITION 3

EDITION 1

Clamp Study I

EDITION 2

EDITION 4

Clamp Study II

Request a Sales Rep

Additional Resources to Support Patients

Register Now for Future Webcasts

Register for free samples of the Toujeo^® Pens^†

Full Toujeo^® Prescribing Information

See what key thought leaders are saying about Toujeo^®

Toujeo^® Dosing Guide

Toujeo^® SoloStar^® Instructions for Use

Toujeo^® Max SoloStar^® Instructions for Use

Starting with Toujeo^®

How Toujeo^® Works

Using the Toujeo^® Pens

Toujeo^® Titration Worksheet

How to Prepare for and Inject Toujeo^®

An Introduction to
Toujeo^® Max SoloStar^®

Toujeo^® Max SoloStar^® Pharmacy FAQs

The recommended starting dose of Toujeo^® is based on prior treatment

After you start Toujeo^®